206 related articles for article (PubMed ID: 30296252)
1. Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.
Li W; Wang Y; Tan S; Rao Q; Zhu T; Huang G; Li Z; Liu G
Med Sci Monit; 2018 Oct; 24():7178-7185. PubMed ID: 30296252
[TBL] [Abstract][Full Text] [Related]
2. Expression of brain‑specific angiogenesis inhibitor‑1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma.
Tian D; Hu H; Sun Y; Tang Y; Lei M; Liu L; Han R; Wu C
Mol Med Rep; 2015 Sep; 12(3):4522-4529. PubMed ID: 26129954
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Caspase-3 and Bcl-2 in bladder transitional carcinoma and their significance].
Shen HW; Yi L; Wang XM; Yao MJ; Deng JW; Fang JZ; Li MN
Ai Zheng; 2004 Feb; 23(2):181-4. PubMed ID: 14960240
[TBL] [Abstract][Full Text] [Related]
4. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 expression in bladder transitional cell carcinoma and its relationship with clinicopathological features.
Li Y; Chen M; Yuan J; Zhou X; He W; Zu X; Qi L
Urol Int; 2014; 92(2):157-63. PubMed ID: 23988662
[TBL] [Abstract][Full Text] [Related]
6. Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis.
Zhang H; Qi F; Cao Y; Chen M; Zu X
Med Sci Monit; 2014 May; 20():812-7. PubMed ID: 24834983
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
9. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
Chow NH; Chan SH; Tzai TS; Ho CL; Liu HS
Clin Cancer Res; 2001 Jul; 7(7):1957-62. PubMed ID: 11448910
[TBL] [Abstract][Full Text] [Related]
11. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
[TBL] [Abstract][Full Text] [Related]
12. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
[TBL] [Abstract][Full Text] [Related]
14. [Differential expression of hyaluronic acid synthase family in human bladder transitional cell carcinoma and its clinical significance].
Cai JL; Li M; Na YQ
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):121-5. PubMed ID: 21575480
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty-acid synthase suppresses P-AKT and induces apoptosis in bladder cancer.
Jiang B; Li EH; Lu YY; Jiang Q; Cui D; Jing YF; Xia SJ
Urology; 2012 Aug; 80(2):484.e9-15. PubMed ID: 22554590
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma.
Zhang H; Guo Y; Song Y; Shang C
Cancer Chemother Pharmacol; 2017 Jan; 79(1):49-55. PubMed ID: 27878359
[TBL] [Abstract][Full Text] [Related]
17. [Significance of activated matrix metalloproteinase 2 (MMP2) in progression of bladder transitional cell carcinoma].
Zhang XP; Zhou FJ; Shen PF; Zhou C; Wei JX
Ai Zheng; 2003 Jun; 22(6):637-9. PubMed ID: 12948424
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
19. Integrin-linked kinase functions as a tumor promoter in bladder transitional cell carcinoma.
Wang DL; Lan JH; Chen L; Huang B; Li Z; Zhao XM; Ma Q; Sheng X; Li WB; Tang WX
Asian Pac J Cancer Prev; 2012; 13(6):2799-806. PubMed ID: 22938462
[TBL] [Abstract][Full Text] [Related]
20. S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy.
Kim WT; Kim J; Yan C; Jeong P; Choi SY; Lee OJ; Chae YB; Yun SJ; Lee SC; Kim WJ
Ann Oncol; 2014 May; 25(5):974-9. PubMed ID: 24631944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]